Exenatide (exendin-4) studies: 530 papers with results
Page 3 of 11
- Effects of exenatide combined with lifestyle modification in patients with type 2 diabetes.
Apovian CM · The American journal of medicine · 2010
Randomized controlled trial · 9 results
- Efficacy of exenatide on weight loss, metabolic parameters and pregnancy in overweight/obese polycystic ovary syndrome.
Liu X · Clinical endocrinology · 2017
Randomized controlled trial · 5 results
- Exenatide plus metformin compared with metformin alone on β-cell function in patients with Type 2 diabetes.
Derosa G · Diabetic medicine : a journal of the British Diabetic Association · 2012
Randomized controlled trial · 19 results
- Variation in inflammatory markers and glycemic parameters after 12 months of exenatide plus metformin treatment compared with metformin alone: a randomized placebo-controlled trial.
Derosa G · Pharmacotherapy · 2013
Randomized controlled trial · 7 results
- Effects of exenatide and metformin in combination on some adipocytokine levels: a comparison with metformin monotherapy.
Derosa G · Canadian journal of physiology and pharmacology · 2013
Randomized controlled trial · 11 results
- Exenatide - pharmacokinetics, pharmacodynamics, safety and tolerability in patients ≥ 75 years of age with Type 2 diabetes.
Linnebjerg H · International journal of clinical pharmacology and therapeutics · 2011
Randomized controlled trial · 8 results
- The Effect of Exenatide Once Weekly on Carotid Atherosclerosis in Individuals With Type 2 Diabetes: An 18-Month Randomized Placebo-Controlled Study.
Koska J · Diabetes care · 2021
Randomized controlled trial · 13 results
- Effects of exenatide on urinary albumin in overweight/obese patients with T2DM: a randomized clinical trial.
Kang C · Scientific reports · 2021
Randomized controlled trial · 6 results
- Treatment satisfaction with ITCA 650, a novel drug-device delivering continuous exenatide, versus twice-daily injections of exenatide in type 2 diabetics using metformin.
Henry R · Diabetes, obesity & metabolism · 2018
Randomized controlled trial · 8 results
- Effects of exenatide and lifestyle modification on body weight and glucose tolerance in obese subjects with and without pre-diabetes.
Rosenstock J · Diabetes care · 2010
Randomized controlled trial · 3 results
- Effect of exenatide after short-time intensive insulin therapy on glycaemic remission maintenance in type 2 diabetes patients: a randomized controlled trial.
Shi X · Scientific reports · 2017
Randomized controlled trial · 6 results
- Exenatide versus glibenclamide in patients with diabetes.
Derosa G · Diabetes technology & therapeutics · 2010
Randomized controlled trial · 13 results
- Exenatide improves glycemic control and reduces body weight in subjects with type 2 diabetes: a dose-ranging study.
Poon T · Diabetes technology & therapeutics · 2005
Randomized controlled trial · 15 results
- Exenatide improves type 2 diabetes concomitant with non-alcoholic fatty liver disease.
Fan H · Arquivos brasileiros de endocrinologia e metabologia · 2013
Randomized controlled trial · 12 results
- The effects of exenatide twice daily compared to insulin lispro added to basal insulin in Latin American patients with type 2 diabetes: A retrospective analysis of the 4B trial.
de Lapertosa SB · Diabetes research and clinical practice · 2016
Randomized controlled trial · 6 results
- Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients.
Derosa G · European journal of pharmacology · 2011
Randomized controlled trial · 7 results
- Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes.
Fineman MS · Diabetes care · 2003
Randomized controlled trial · 5 results
- A direct comparison of long- and short-acting GLP-1 receptor agonists (taspoglutide once weekly and exenatide twice daily) on postprandial metabolism after 24 weeks of treatment.
Gastaldelli A · Diabetes, obesity & metabolism · 2014
Randomized controlled trial · 10 results
- Effects of short-acting exenatide added three times daily to insulin therapy on bone metabolism in type 1 diabetes.
Johansen NJ · Diabetes, obesity & metabolism · 2022
Randomized controlled trial · 7 results
- The Glucagon-Like Peptide-1 Analog Exenatide Increases Blood Glucose Clearance, Lactate Clearance, and Heart Rate in Comatose Patients After Out-of-Hospital Cardiac Arrest.
Wiberg S · Critical care medicine · 2018
Randomized controlled trial · 5 results
- Effectiveness of progressive dose-escalation of exenatide (exendin-4) in reducing dose-limiting side effects in subjects with type 2 diabetes.
Fineman MS · Diabetes/metabolism research and reviews · 2004
Randomized controlled trial · 5 results
- Circulating zinc-α2-glycoprotein is reduced in women with polycystic ovary syndrome, but can be increased by exenatide or metformin treatment.
Zheng S · Endocrine journal · 2019
Randomized controlled trial · 2 results
- Effects of Exenatide and Humalog Mix25 on Fat Distribution, Insulin Sensitivity, and β-Cell Function in Normal BMI Patients with Type 2 Diabetes and Visceral Adiposity.
Wang X · Journal of diabetes research · 2020
Randomized controlled trial · 7 results
- Exenatide has a pronounced effect on energy intake but not energy expenditure in non-diabetic subjects with obesity: A randomized, double-blind, placebo-controlled trial.
Basolo A · Metabolism: clinical and experimental · 2018
Randomized controlled trial · 11 results
- The effect of chronic twice daily exenatide treatment on β-cell function in new onset type 2 diabetes.
Gastaldelli A · Clinical endocrinology · 2014
Randomized controlled trial · 14 results
- Effect of the GLP-1 receptor agonist exenatide on pro-inflammatory and metabolic biomarkers in individuals with alcohol use disorder: Post hoc results from a randomized, double-blinded, placebo-controlled clinical trial.
Hviid MEB · Alcohol, clinical & experimental research · 2025
Randomized controlled trial · 1 result
- Efficacy of exenatide and insulin glargine on nonalcoholic fatty liver disease in patients with type 2 diabetes.
Liu L · Diabetes/metabolism research and reviews · 2020
Randomized controlled trial · 12 results
- Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia.
Lønborg J · Circulation. Cardiovascular interventions · 2012
Randomized controlled trial · 6 results
- Mathematical modeling shows exenatide improved beta-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea.
Mari A · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2006
Randomized controlled trial · 6 results
- One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial.
Bunck MC · Diabetes care · 2009
Randomized controlled trial · 6 results
- Locally delivered GLP-1 analogues liraglutide and exenatide enhance microvascular perfusion in individuals with and without type 2 diabetes.
Aung MM · Diabetologia · 2019
Randomized controlled trial · 10 results
- A thorough QT study to evaluate the effects of singledose exenatide 10 μg on cardiac repolarization in healthy subjects.
Linnebjerg H · International journal of clinical pharmacology and therapeutics · 2011
Randomized controlled trial · 4 results
- Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study.
DeFronzo RA · Current medical research and opinion · 2008
Randomized controlled trial · 10 results
- Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes.
Shao N · Diabetes/metabolism research and reviews · 2014
Randomized controlled trial · 15 results
- Efficacy and tolerability of exenatide monotherapy in obese patients with newly diagnosed type 2 diabetes: a randomized, 26 weeks metformin-controlled, parallel-group study.
Yuan GH · Chinese medical journal · 2012
Randomized controlled trial · 13 results
- Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
Woo JS · Arteriosclerosis, thrombosis, and vascular biology · 2013
Randomized controlled trial · 6 results
- Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: A post-hoc analysis of a 52-week randomised trial.
Muskiet MHA · Diabetes research and clinical practice · 2019
Randomized controlled trial · 10 results
- Effects of exenatide vs. metformin on endothelial function in obese patients with pre-diabetes: a randomized trial.
Kelly AS · Cardiovascular diabetology · 2012
Randomized controlled trial · 6 results
- Safety and efficacy of twice-daily exenatide in Taiwanese patients with inadequately controlled type 2 diabetes mellitus.
Lu CH · Journal of the Formosan Medical Association = Taiwan yi zhi · 2013
Randomized controlled trial · 7 results
- Efficacy and safety of exenatide as add-on therapy for patients with type 2 diabetes with an intensive insulin regimen: A randomized double-blind trial.
Joubert M · Diabetes, obesity & metabolism · 2021
Randomized controlled trial · 8 results
- Exenatide and the treatment of patients with Parkinson's disease.
Aviles-Olmos I · The Journal of clinical investigation · 2013
Randomized controlled trial · 5 results
- Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease.
Aviles-Olmos I · Journal of Parkinson's disease · 2014
Randomized controlled trial · 2 results
- Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy.
Dutour A · Diabetes, obesity & metabolism · 2016
Randomized controlled trial · 8 results
- Effects of exenatide and liraglutide on 24-hour glucose fluctuations in type 2 diabetes.
Nagakura J · Endocrine journal · 2016
Randomized controlled trial · 12 results
- Pharmacokinetics of an oral drug (acetaminophen) administered at various times in relation to subcutaneous injection of exenatide (exendin-4) in healthy subjects.
Blase E · Journal of clinical pharmacology · 2005
Randomized controlled trial · 5 results
- Effects of insulin and exenatide therapy on glycemic control and β-cell function in patients newly diagnosed with type 2 diabetes and severe hyperglycemia.
Wu TH · Journal of the Chinese Medical Association : JCMA · 2026
Randomized controlled trial · 7 results
- Effect of continuous exenatide infusion on cardiac function and peri-operative glucose control in patients undergoing cardiac surgery: A single-blind, randomized controlled trial.
Lipš M · Diabetes, obesity & metabolism · 2017
Randomized controlled trial · 5 results
- Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetes.
Bunck MC · Diabetes care · 2011
Randomized controlled trial · 4 results
- Exenatide improves β-cell function up to 3 years of treatment in patients with type 2 diabetes: a randomised controlled trial.
van Raalte DH · European journal of endocrinology · 2016
Randomized controlled trial · 8 results
- Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus.
Schwartz EA · Atherosclerosis · 2010
Randomized controlled trial · 7 results